Scheduled versus Pro Re Nata Dosing in the VIEW Trials.
Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES: A Literature Review and Consensus Recommendations.
Increased Fundus Autofluorescence and Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration: The GAIN Study.
CHROMA: Clinical Trial of Lampalizumab for Geographic Atrophy Secondary to Age-Related Macular Degeneration
FOVISTA NR: Clinical Trial for neovascular age-related macular degeneration
LITE: Development of Advanced Laser Imaging Techniques for the anterior and posterior Eye
FOVISTA: Clinical Trial for subfoveal neovascular age-related macular degeneration
Clinical trial in antiretroviral-naive patients with choroidal neovascularization secondary to AMD
Phase III Study of Lampalizumab in patients with geographic atrophy secondary to AMD
MPL4 GA: A phase I study in subjects with geographic atrophy secondary to dry age-related macular degeneration
Oral Omega 3 GA. A phase II in subjects with geographic atrophy secondary to AMD
A delphi study to detect deficiencies and propose actions in real life treatment of neovascular age-related macular degeneration.
Sustained delivery fluocinolone acetonide vitreous implants: long-term benefit in patients with chronic diabetic macular edema.